These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36852863)

  • 1. Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells.
    Aiewsakun P; Phumiphanjarphak W; Ludowyke N; Purwono PB; Manopwisedjaroen S; Srisaowakarn C; Ekronarongchai S; Suksatu A; Yuvaniyama J; Thitithanyanont A
    Genome Biol Evol; 2023 Apr; 15(4):. PubMed ID: 36852863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases.
    Chaudhry MZ; Eschke K; Hoffmann M; Grashoff M; Abassi L; Kim Y; Brunotte L; Ludwig S; Kröger A; Klawonn F; Pöhlmann SH; Cicin-Sain L
    J Virol; 2022 Mar; 96(5):e0218621. PubMed ID: 35019723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propagation of SARS-CoV-2 in Calu-3 Cells to Eliminate Mutations in the Furin Cleavage Site of Spike.
    Baczenas JJ; Andersen H; Rashid S; Yarmosh D; Puthuveetil N; Parker M; Bradford R; Florence C; Stemple KJ; Lewis MG; O'Connor SL
    Viruses; 2021 Dec; 13(12):. PubMed ID: 34960703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology.
    Ogando NS; Dalebout TJ; Zevenhoven-Dobbe JC; Limpens RWAL; van der Meer Y; Caly L; Druce J; de Vries JJC; Kikkert M; Bárcena M; Sidorov I; Snijder EJ
    J Gen Virol; 2020 Sep; 101(9):925-940. PubMed ID: 32568027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication kinetics and infectivity of SARS-CoV-2 variants of concern in common cell culture models.
    Mautner L; Hoyos M; Dangel A; Berger C; Ehrhardt A; Baiker A
    Virol J; 2022 Apr; 19(1):76. PubMed ID: 35473640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of SARS-CoV-2 Spike Mutations on Its Activation by TMPRSS2 and the Alternative TMPRSS13 Protease.
    Stevaert A; Van Berwaer R; Mestdagh C; Vandeput J; Vanstreels E; Raeymaekers V; Laporte M; Naesens L
    mBio; 2022 Aug; 13(4):e0137622. PubMed ID: 35913162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 growth, furin-cleavage-site adaptation and neutralization using serum from acutely infected hospitalized COVID-19 patients.
    Klimstra WB; Tilston-Lunel NL; Nambulli S; Boslett J; McMillen CM; Gilliland T; Dunn MD; Sun C; Wheeler SE; Wells A; Hartman AL; McElroy AK; Reed DS; Rennick LJ; Duprex WP
    J Gen Virol; 2020 Nov; 101(11):1156-1169. PubMed ID: 32821033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of SARS-CoV-2 Evolution in Paediatric Primary Airway Epithelial Cell Cultures Compared with Vero-Derived Cell Lines.
    Bamford CGG; Broadbent L; Aranday-Cortes E; McCabe M; McKenna J; Courtney DG; Touzelet O; Ali A; Roberts G; Lopez Campos G; Simpson D; McCaughey C; Fairley D; Mills K; Power UF; On Behalf Of The Breathing Together Investigators
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2.
    Criscuolo E; Giuliani B; Ferrari D; Ferrarese R; Diotti RA; Clementi M; Mancini N; Clementi N
    Viruses; 2022 Jun; 14(6):. PubMed ID: 35746703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insights into the Replication Kinetics Profiles of Malaysian SARS-CoV-2 Variant Alpha, Beta, Delta, and Omicron in Vero E6 Cell Line.
    Mohd Zawawi Z; Kalyanasundram J; Mohd Zain R; Mat Ripen A; Basri DF; Yap WB
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
    Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
    Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of SARS-CoV-2 spike-pseudotyped retroviral vector inducing syncytia formation.
    Lee SY; Kim DW; Jung YT
    Virus Genes; 2022 Jun; 58(3):172-179. PubMed ID: 35322356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging SARS-CoV-2 Genotypes Show Different Replication Patterns in Human Pulmonary and Intestinal Epithelial Cells.
    de Souza GAP; Le Bideau M; Boschi C; Ferreira L; Wurtz N; Devaux C; Colson P; La Scola B
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Clinical-Stage Cysteine Protease Inhibitor blocks SARS-CoV-2 Infection of Human and Monkey Cells.
    Mellott DM; Tseng CT; Drelich A; Fajtová P; Chenna BC; Kostomiris DH; Hsu J; Zhu J; Taylor ZW; Kocurek KI; Tat V; Katzfuss A; Li L; Giardini MA; Skinner D; Hirata K; Yoon MC; Beck S; Carlin AF; Clark AE; Beretta L; Maneval D; Hook V; Frueh F; Hurst BL; Wang H; Raushel FM; O'Donoghue AJ; de Siqueira-Neto JL; Meek TD; McKerrow JH
    ACS Chem Biol; 2021 Apr; 16(4):642-650. PubMed ID: 33787221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heme oxygenase-1 inducer hemin does not inhibit SARS-CoV-2 virus infection.
    Maestro S; Córdoba KM; Olague C; Argemi J; Ávila MA; González-Aseguinolaza G; Smerdou C; Fontanellas A
    Biomed Pharmacother; 2021 May; 137():111384. PubMed ID: 33761605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication.
    Ramirez S; Fernandez-Antunez C; Galli A; Underwood A; Pham LV; Ryberg LA; Feng S; Pedersen MS; Mikkelsen LS; Belouzard S; Dubuisson J; Sølund C; Weis N; Gottwein JM; Fahnøe U; Bukh J
    Antimicrob Agents Chemother; 2021 Jun; 65(7):e0009721. PubMed ID: 33903110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 variants reveal features critical for replication in primary human cells.
    Pohl MO; Busnadiego I; Kufner V; Glas I; Karakus U; Schmutz S; Zaheri M; Abela I; Trkola A; Huber M; Stertz S; Hale BG
    PLoS Biol; 2021 Mar; 19(3):e3001006. PubMed ID: 33760807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2 variants with mutations at the S1/S2 cleavage site are generated in vitro during propagation in TMPRSS2-deficient cells.
    Sasaki M; Uemura K; Sato A; Toba S; Sanaki T; Maenaka K; Hall WW; Orba Y; Sawa H
    PLoS Pathog; 2021 Jan; 17(1):e1009233. PubMed ID: 33476327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The furin cleavage site in the SARS-CoV-2 spike protein is required for transmission in ferrets.
    Peacock TP; Goldhill DH; Zhou J; Baillon L; Frise R; Swann OC; Kugathasan R; Penn R; Brown JC; Sanchez-David RY; Braga L; Williamson MK; Hassard JA; Staller E; Hanley B; Osborn M; Giacca M; Davidson AD; Matthews DA; Barclay WS
    Nat Microbiol; 2021 Jul; 6(7):899-909. PubMed ID: 33907312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.